{"id":"https://openalex.org/W2037595197","doi":"https://doi.org/10.1517/13543784.2014.918951","title":"NMDA antagonists under investigation for the treatment of major depressive disorder","display_name":"NMDA antagonists under investigation for the treatment of major depressive disorder","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-12","ids":{"openalex":"https://openalex.org/W2037595197","doi":"https://doi.org/10.1517/13543784.2014.918951","mag":"2037595197","pmid":"https://pubmed.ncbi.nlm.nih.gov/24818801"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.2014.918951","doi":"https://doi.org/10.1517/13543784.2014.918951","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2014.918951","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2037595197"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://ruj.uj.edu.pl/xmlui/handle/item/110926","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028212666","display_name":"Bart\u0142omiej Pochwat","orcid":"https://orcid.org/0000-0002-3785-6721","observed_orcids":["https://orcid.org/0000-0002-3785-6721"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bart\u0142omiej Pochwat","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Poland","Institute of Pharmacology Polish Academy of Sciences , Smetna 12, PL 31-343, Krakow, Poland. szewczyk@if-pan.krakow.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Poland","institution_ids":["https://openalex.org/I99542240"]},{"raw_affiliation_string":"Institute of Pharmacology Polish Academy of Sciences , Smetna 12, PL 31-343, Krakow, Poland. szewczyk@if-pan.krakow.pl","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052898318","display_name":"Agnieszka Pa\u0142ucha-Poniewiera","orcid":"https://orcid.org/0000-0001-9890-6844","observed_orcids":["https://orcid.org/0000-0001-9890-6844"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Agnieszka Pa\u0142ucha-Poniewiera","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Poland","Institute of Pharmacology Polish Academy of Sciences , Smetna 12, PL 31-343, Krakow, Poland. szewczyk@if-pan.krakow.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Poland","institution_ids":["https://openalex.org/I99542240"]},{"raw_affiliation_string":"Institute of Pharmacology Polish Academy of Sciences , Smetna 12, PL 31-343, Krakow, Poland. szewczyk@if-pan.krakow.pl","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045678056","display_name":"Bernadeta Szewczyk","orcid":"https://orcid.org/0000-0002-6863-7951","observed_orcids":["https://orcid.org/0000-0002-6863-7951"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernadeta Szewczyk","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Poland","Institute of Pharmacology Polish Academy of Sciences , Smetna 12, PL 31-343, Krakow, Poland. szewczyk@if-pan.krakow.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Poland","institution_ids":["https://openalex.org/I99542240"]},{"raw_affiliation_string":"Institute of Pharmacology Polish Academy of Sciences , Smetna 12, PL 31-343, Krakow, Poland. szewczyk@if-pan.krakow.pl","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082517862","display_name":"Andrzej Pilc","orcid":"https://orcid.org/0000-0002-4045-0597","observed_orcids":["https://orcid.org/0000-0002-4045-0597"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]},{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrzej Pilc","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Poland","Jagiellonian University Medical College, Department of Drug Management, Poland","Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, PL 31-343 Krak\u00f3w, Poland szewczyk@if-pan.krakow.pl; Jagiellonian University Medical College, Department of Drug Management, Grzeg\u00f3rzecka 20, PL 31-531 Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Poland","institution_ids":["https://openalex.org/I99542240"]},{"raw_affiliation_string":"Jagiellonian University Medical College, Department of Drug Management, Poland","institution_ids":["https://openalex.org/I126596746"]},{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, PL 31-343 Krak\u00f3w, Poland szewczyk@if-pan.krakow.pl; Jagiellonian University Medical College, Department of Drug Management, Grzeg\u00f3rzecka 20, PL 31-531 Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I126596746","https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044015773","display_name":"Gabriel Nowak","orcid":"https://orcid.org/0000-0002-3000-7938","observed_orcids":["https://orcid.org/0000-0002-3000-7938"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]},{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriel Nowak","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Poland","Jagiellonian University Medical College, Department of Pharmacobiology, Poland","Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, PL 31-343 Krak\u00f3w, Poland szewczyk@if-pan.krakow.pl; Jagiellonian University Medical College, Department of Pharmacobiology, Medyczna 9, PL 30-688 Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Poland","institution_ids":["https://openalex.org/I99542240"]},{"raw_affiliation_string":"Jagiellonian University Medical College, Department of Pharmacobiology, Poland","institution_ids":["https://openalex.org/I126596746"]},{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, PL 31-343 Krak\u00f3w, Poland szewczyk@if-pan.krakow.pl; Jagiellonian University Medical College, Department of Pharmacobiology, Medyczna 9, PL 30-688 Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I126596746","https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1658,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.72916667,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"23","issue":"9","first_page":"1181","last_page":"1192"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.9829999804496765},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.7210000157356262},{"id":"https://openalex.org/keywords/antidepressant-mechanism-of-action","display_name":"antidepressant mechanism","score":0.6869999766349792},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.8479999899864197},{"id":"https://openalex.org/keywords/rapid-acting-antidepressants","display_name":"rapid-acting antidepressants","score":0.7239999771118164},{"id":"https://openalex.org/keywords/cp-101-606","display_name":"CP-101,606","score":0.9089999794960022},{"id":"https://openalex.org/keywords/d-cycloserine","display_name":"D-cycloserine","score":0.9269999861717224},{"id":"https://openalex.org/keywords/glun2b-subunit","display_name":"GluN2B subunit","score":0.7950000166893005},{"id":"https://openalex.org/keywords/psychotomimetic-effects","display_name":"psychotomimetic effects","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.8517329692840576},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.7201213836669922},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6731100082397461},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6191657185554504},{"id":"https://openalex.org/C2777134132","wikidata":"https://www.wikidata.org/wiki/Q188638","display_name":"Mood disorders","level":3,"score":0.5715101957321167},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5524267554283142},{"id":"https://openalex.org/C2778875871","wikidata":"https://www.wikidata.org/wiki/Q4764954","display_name":"Animal models of depression","level":4,"score":0.548416793346405},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.5259283185005188},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5147992968559265},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45599597692489624},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.43472328782081604},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.4310421943664551},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.4288055896759033},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4101022779941559},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3410055637359619},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.2418358027935028},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18851009011268616},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.16061115264892578},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12980377674102783},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018690","descriptor_name":"Excitatory Amino Acid Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018690","descriptor_name":"Excitatory Amino Acid Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018690","descriptor_name":"Excitatory Amino Acid Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1517/13543784.2014.918951","doi":"https://doi.org/10.1517/13543784.2014.918951","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2014.918951","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:24818801","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24818801","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"},{"id":"pmh:oai:ruj.uj.edu.pl:item/110926","doi":null,"is_oa":true,"landing_page_url":"https://ruj.uj.edu.pl/xmlui/handle/item/110926","pdf_url":null,"source":{"id":"https://openalex.org/S4306400316","display_name":"Homo Politicus (Academy of Humanities and Economics in Lodz)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"artyku\u0142 w czasopi\u015bmie"},{"id":"pmh:oai:ruj.uj.edu.pl:item/120608","doi":null,"is_oa":true,"landing_page_url":"https://ruj.uj.edu.pl/xmlui/handle/item/120608","pdf_url":null,"source":{"id":"https://openalex.org/S4306401249","display_name":"Jagiellonian University Repository (Jagiellonian University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126596746","host_organization_name":"Jagiellonian University","host_organization_lineage":["https://openalex.org/I126596746"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:ruj.uj.edu.pl:item/133571","doi":null,"is_oa":true,"landing_page_url":"https://ruj.uj.edu.pl/xmlui/handle/item/133571","pdf_url":null,"source":{"id":"https://openalex.org/S4306400316","display_name":"Homo Politicus (Academy of Humanities and Economics in Lodz)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"artyku\u0142 w czasopi\u015bmie"},{"id":"pmh:oai:ruj.uj.edu.pl:item/95376","doi":null,"is_oa":false,"landing_page_url":"https://ruj.uj.edu.pl/xmlui/handle/item/95376","pdf_url":null,"source":{"id":"https://openalex.org/S4306400316","display_name":"Homo Politicus (Academy of Humanities and Economics in Lodz)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"artyku\u0142 w czasopi\u015bmie"}],"best_oa_location":{"id":"pmh:oai:ruj.uj.edu.pl:item/110926","doi":null,"is_oa":true,"landing_page_url":"https://ruj.uj.edu.pl/xmlui/handle/item/110926","pdf_url":null,"source":{"id":"https://openalex.org/S4306400316","display_name":"Homo Politicus (Academy of Humanities and Economics in Lodz)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"artyku\u0142 w czasopi\u015bmie"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":98,"referenced_works":["https://openalex.org/W84262307","https://openalex.org/W1914381346","https://openalex.org/W1964466640","https://openalex.org/W1966000564","https://openalex.org/W1969644317","https://openalex.org/W1970448316","https://openalex.org/W1972183007","https://openalex.org/W1976392245","https://openalex.org/W1981097208","https://openalex.org/W1984858305","https://openalex.org/W1985086901","https://openalex.org/W1986008985","https://openalex.org/W1986035671","https://openalex.org/W1988244113","https://openalex.org/W1991621530","https://openalex.org/W1993254026","https://openalex.org/W1993300625","https://openalex.org/W1997962734","https://openalex.org/W2000825037","https://openalex.org/W2002118034","https://openalex.org/W2002580140","https://openalex.org/W2004331086","https://openalex.org/W2005871900","https://openalex.org/W2006861654","https://openalex.org/W2006960210","https://openalex.org/W2011804248","https://openalex.org/W2012091005","https://openalex.org/W2018114814","https://openalex.org/W2019247974","https://openalex.org/W2019754485","https://openalex.org/W2020789218","https://openalex.org/W2022873534","https://openalex.org/W2022994360","https://openalex.org/W2023081218","https://openalex.org/W2023928627","https://openalex.org/W2027744361","https://openalex.org/W2027873424","https://openalex.org/W2028423021","https://openalex.org/W2029714528","https://openalex.org/W2032739515","https://openalex.org/W2036877455","https://openalex.org/W2037231243","https://openalex.org/W2042166364","https://openalex.org/W2044325416","https://openalex.org/W2047193476","https://openalex.org/W2047397795","https://openalex.org/W2049022403","https://openalex.org/W2049563161","https://openalex.org/W2049906849","https://openalex.org/W2050489286","https://openalex.org/W2054596536","https://openalex.org/W2055158951","https://openalex.org/W2056041130","https://openalex.org/W2064478935","https://openalex.org/W2067166581","https://openalex.org/W2067230536","https://openalex.org/W2067937090","https://openalex.org/W2070828096","https://openalex.org/W2071430187","https://openalex.org/W2083681242","https://openalex.org/W2086305648","https://openalex.org/W2087592711","https://openalex.org/W2088050000","https://openalex.org/W2089066634","https://openalex.org/W2089351762","https://openalex.org/W2089394160","https://openalex.org/W2090966488","https://openalex.org/W2091363925","https://openalex.org/W2094730014","https://openalex.org/W2095159395","https://openalex.org/W2097152162","https://openalex.org/W2103255996","https://openalex.org/W2107523578","https://openalex.org/W2108212317","https://openalex.org/W2108403304","https://openalex.org/W2108980934","https://openalex.org/W2109334244","https://openalex.org/W2113902650","https://openalex.org/W2116635659","https://openalex.org/W2118815581","https://openalex.org/W2121117021","https://openalex.org/W2129411932","https://openalex.org/W2131812309","https://openalex.org/W2132249192","https://openalex.org/W2137992068","https://openalex.org/W2144269887","https://openalex.org/W2146645762","https://openalex.org/W2148942933","https://openalex.org/W2157040702","https://openalex.org/W2159968743","https://openalex.org/W2160011621","https://openalex.org/W2167517090","https://openalex.org/W2172219833","https://openalex.org/W2245679498","https://openalex.org/W2268719527","https://openalex.org/W2319946110","https://openalex.org/W4406066372","https://openalex.org/W7073860366"],"related_works":["https://openalex.org/W2046489639","https://openalex.org/W2208574896","https://openalex.org/W2055661286","https://openalex.org/W2111728433","https://openalex.org/W2158031806","https://openalex.org/W2132249192","https://openalex.org/W2320687740","https://openalex.org/W2952344926","https://openalex.org/W2167517090","https://openalex.org/W2009336731"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Mood":[1],"disorders,":[2],"including":[3],"depression,":[4],"are":[5,123,159],"becoming":[6],"increasingly":[7],"prevalent":[8],"in":[9,134],"the":[10,20,61,66,76,79,114,141],"developed":[11],"world.":[12],"Furthermore,":[13,75],"treatment":[14],"of":[15,33,47,68,81,108,143],"depression":[16],"therapeutics,":[17],"mainly":[18],"influencing":[19],"serotonergic":[21],"and":[22,49,153],"adrenergic":[23],"systems,":[24],"is":[25],"considered":[26],"insufficient.":[27],"The":[28],"original":[29],"NMDA-glutamate":[30],"hypothesis":[31],"mechanism":[32],"antidepressant":[34,82,129],"action":[35,83],"was":[36],"first":[37],"proposed":[38],"\u223c":[39],"20":[40],"years":[41],"ago.":[42],"Since":[43],"then,":[44],"a":[45],"number":[46],"preclinical":[48,87],"clinical":[50,63,92,138],"studies":[51,93],"have":[52],"examined":[53],"its":[54],"rationale.":[55],"AREAS":[56],"COVERED:":[57],"This":[58],"review":[59],"highlights":[60],"recent":[62],"evidence":[64],"for":[65,105,127,132,140],"use":[67,95,133,142],"functional":[69],"NMDA":[70,100,119,149],"receptor":[71,120,150],"antagonists":[72,121],"as":[73,102],"antidepressants.":[74],"authors":[77],"present":[78],"mechanism(s)":[80],"derived":[84],"mostly":[85,94],"from":[86],"paradigms.":[88],"EXPERT":[89],"OPINION:":[90],"Currently,":[91],"ketamine":[96],"(a":[97],"noncompetitive":[98],"high-potency":[99],"antagonist)":[101],"an":[103],"agent":[104],"rapid":[106,128],"relief":[107],"depressive":[109],"symptoms.":[110],"However,":[111],"due":[112],"to":[113],"ketamine-induced":[115],"psychotomimetic":[116],"effects,":[117],"new":[118],"(modulators)":[122],"continuously":[124],"being":[125],"introduced":[126],"action,":[130],"especially":[131],"treatment-resistant":[135],"patients.":[136],"Recent":[137],"reports":[139],"CP-101,606,":[144],"MK-0657":[145],"(selective":[146],"GluN2B":[147],"subunit":[148],"antagonists),":[151],"GLYX-13":[152],"d-cycloserine":[154],"(glycine":[155],"site":[156],"partial":[157],"agonists)":[158],"optimistic":[160],"but":[161],"await":[162],"further":[163],"support.":[164]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2037595197","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
